BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

LA BioMed Recognized by the Association for the Accreditation of Human Research Protection Programs


12/18/2012 12:46:55 PM

LOS ANGELES (Dec. 18, 2012) – The Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed), recognized as a leader in groundbreaking medical advancements and for bringing laboratory discoveries from the bench to the bedside, recently received accreditation from the Association for the Accreditation of Human Research Protection Programs, Inc. (AAHRPP). LA BioMed was one of five entities whose accreditation was approved at the meeting of AAHRPP’s Council on Accreditation in December.

“We are pleased to have been recognized for our outstanding program in the protection of human research subjects,” said David I. Meyer, Ph.D., President and CEO at LA BioMed. “Excellence in that area puts us in the position to carry out clinical research and trials of new drugs and devices with the utmost attention to protecting research subjects, while at the same time promoting cutting edge innovations.”

This year, LA BioMed celebrates 60 years of achievements in turning innovative science into breakthrough medicine for patients in need. The Institute’s clinician-scientists have successfully developed treatments and therapies to treat conditions that affect individuals in the local community and abroad, including antibiotic-resistant infectious diseases, cancer, HIV/AIDS transmission, mental health, heart disease, diabetes, pulmonary hypertension, improper nutrition, and many other life-threatening conditions. LA BioMed has also made tremendous progress with its master plan to consolidate its facilities into a modern 11-acre research park that will bring leading scientists and physicians together to lead in breakthrough medical discoveries.

For the past decade, AAHRPP has granted accreditations to research programs and organizations that conduct biomedical, behavioral, or social sciences research involving human participants, and that meet the highest standards for research quality, ethics, and protection of research participants. AAHRPP is dedicated to protecting as many participants as possible, while ensuring that the world reaps the benefits of research.

About LA BioMed

Founded in 1952, LA BioMed is one of the country’s leading nonprofit independent biomedical research institutes. It has approximately 100 principal researchers conducting studies into medical genetics, infectious diseases, and chronic cardiovascular and pulmonary illnesses. It also educates young scientists and provides community services, including prenatal counseling and childhood nutrition programs. LA BioMed is academically affiliated with the David Geffen School of Medicine at UCLA and located on the campus of Harbor-UCLA Medical Center. For more information, please visit www.LABioMed.org.

About the Association for the Accreditation of Human Research Protection Programs

A nonprofit organization, AAHRPP provides accreditation for organizations that conduct human research and can demonstrate that their protections exceed the safeguards required by the U.S. government. To learn more, visit www.aahrpp.org.


Read at BioSpace.com


LA BioMed
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->